Okay, let's tackle this question. The user is asking about long-acting sympathomimetics used in bronchial asthma. First, I need to recall what sympathomimetics are. They are drugs that mimic the effects of the sympathetic nervous system, typically by stimulating adrenergic receptors. Sympathomimetics can be divided into direct-acting (like epinephrine, norepinephrine) and indirect-acting (like amphetamines).

Now, the question specifies long-acting ones. In the context of bronchial asthma, the primary concern is bronchodilation. Beta-2 adrenergic agonists are the mainstay for this. Short-acting beta-2 agonists (SABAs) like albuterol are used for acute relief, while long-acting beta-2 agonists (LABAs) are for maintenance. Examples of LABAs include salmeterol and formoterol. These act on beta-2 receptors in the airways, causing smooth muscle relaxation and bronchodilation.

Wait, but the question is about sympathomimetics. Are there other sympathomimetics besides beta-2 agonists? Epinephrine is a sympathomimetic, but it's short-acting. Ephedrine, which is a sympathomimetic amine, has longer action but is less selective. However, in asthma, the primary long-acting agents are LABAs. So the correct answer here is likely salmeterol or formoterol.

Looking at the options, the user hasn't provided them, but common distractors might include SABAs like albuterol, or other drugs like theophylline (which is a methylxanthine), or anticholinergics. Also, maybe some other sympathomimetics like ephedrine or epinephrine. So the key is to differentiate between short-acting and long-acting beta-2 agonists.

The core concept here is the classification of beta-agonists based on duration of action and their use in asthma. The correct answer is a LABA, so in the options, if one of them is salmeterol, that's the right choice. The wrong options would include SABAs or other drugs not classified as sympathomimetics.

I should also remember that LABAs are used in combination with inhaled corticosteroids for long-term control. They shouldn't be used as monotherapy. The clinical pearl here is that LABAs are long-acting beta-2 agonists used in asthma management, and they must be paired with anti-inflammatory agents to prevent exacerbations.

**Core Concept**
Long-acting sympathomimetics in bronchial asthma primarily refer to **long-acting beta-2 adrenergic agonists (LABAs)** like salmeterol and formoterol. These agents stimulate beta-2 receptors in bronchial smooth muscle, causing sustained bronchodilation over 12–24 hours, making them essential for maintenance therapy in chronic asthma.

**Why the Correct Answer is Right**
**Salmeterol** is a selective LABA with a slow onset and prolonged duration of action (12–24 hours). It binds to beta-2 adrenergic receptors in airway smooth muscle, activating adenylate cyclase to increase cAMP levels. This inhib

✓ Correct Answer: D. Salmeterol